Life Science Today
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs.
Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
The Niche Episode 058¬ – BGI Group, Genebass, Astellas, Seagen, Parexel, Hyperfine SPAC
Muddy waters of data privacy and genetic databases, antibody-drug conjugate approvals, unabetted wild enthusiasm for CROs, and mobile MRIs go public.
Story References
https://tinyurl.com/Niche-058-1
https://tinyurl.com/Niche-058-2
https://tinyurl.com/Niche-058-3
https://tinyurl.com/Niche-058-4
https://tinyurl.com/Niche-058-5
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
About The Niche Podcast
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 057 – Bonus Interview with Dr. Jayne Morgan, Executive Director COVID19 Task Force
Welcome to a special bonus episode as we kick off Season 2 the Niche Podcast. I sat down with Dr. Jayne Morgan, the head of the COVID19 task force at Piedmont Healthcare to talk about her career in clinical research.
Sponsors
https://www.thescopemethod.com
Dr. Morgan on LinkedIn
https://tinyurl.com/Niche-057-1
Dr. Morgan on Instagram
https://tinyurl.com/Niche-057-2
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
About The Niche Podcast
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 056 – End of Season 1, Biogen, Pfizer, Eli Lilly, Intellia (CRISPR)
This is the last episode of Season 1 of the Niche Podcast. In line with that, I’ve got some announcements right at the top of the episode. Also, this week, congressional brakes, internal brakes, FDA brakes, and the first human CRISPR data.
Story References
https://tinyurl.com/Niche-056-1
https://tinyurl.com/Niche-056-2
https://tinyurl.com/Niche-056-3
https://tinyurl.com/Niche-056-4
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 055 – Kidney Foundation, Elanco + Kindred Bio, Danaher + Aldevron, Verve, Lyell
Kidney research, pet health, manufacturing is valuable, and a couple of biotech IPOs
Sponsors
https://www.thescopemethod.com
Story References
https://tinyurl.com/Niche-055-1
https://tinyurl.com/Niche-055-2
https://tinyurl.com/Niche-055-3
https://tinyurl.com/Niche-055-4
https://tinyurl.com/Niche-055-5
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 054 – Aduhelm + Alzheimer’s, Regeneron Execs, CROS NT + Alira Health, FDA Recall
We dive deep into Alzheimer’s, Regeneron execs might be overpaid, a merger in clinical research, and the FDA issues a Class 1 recall
Sponsors
https://www.thescopemethod.com
Story References
https://tinyurl.com/Niche-054-1
https://tinyurl.com/Niche-054-2
https://tinyurl.com/Niche-054-3
https://tinyurl.com/Niche-054-4
https://tinyurl.com/Niche-054-5
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
The Niche Episode 053 – All About FDA Approvals
Pending FDA approvals, expanded FDA approvals, new FDA approvals, and a lawsuit about FDA approvals.
Sponsors
https://www.thescopemethod.com
Story References
https://tinyurl.com/Niche-053-1
https://tinyurl.com/Niche-053-2
https://tinyurl.com/Niche-053-3
https://tinyurl.com/Niche-053-4
https://tinyurl.com/Niche-053-5
https://tinyurl.com/Niche-053-6
Music by Luke Goodson
https://www.soundcloud.com/lukegoodson
The Niche Podcast brings you interviews with industry experts and top stories from last week in biotech, pharma, clinical research, and the life science industries. You can expect highlights about new technologies, biotech and pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to IPOs. The Niche also tries to highlight trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed, move through clinical trials, and become approved by regulatory agencies. It’s news, with a dash of perspective, focused on these Niche industries.
Responses